ClinicalTrials.Veeva

Menu

Effect of Non-invasive Vagus Nerve Stimulation on Cognitive Functions in Diabetic Polyneuropathy Patients

H

heba ahmed khalifa

Status

Active, not recruiting

Conditions

Diabetic Peripheral Neuropathy

Treatments

Device: Vagus nerve stimulation
Other: A computer based cognitive rehabilitation program (Rehacom system)

Study type

Interventional

Funder types

Other

Identifiers

NCT06048653
P.T.REC/012/003942

Details and patient eligibility

About

Diabetic peripheral neuropathy (DPN) occurs due to long standing hyperglycemia and associated metabolic derangements. Cognitive impairment is a common complication in diabetes mellitus. It is associated with a faster rate of cognitive decline.

Full description

This research aims to

  • determine the effect of non-invasive Vagus nerve stimulation on cognitive functions in diabetic peripheral neuropathy.
  • investigate the correlation between cognitive function and severity of diabetic neuropathy.
  • investigate the correlation between cognitive function and quality of life in diabetic peripheral neuropathy.

Enrollment

40 patients

Sex

Female

Ages

40 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with diabetic polyneuropathy
  • Female patients.
  • age ranges from 40 to 55 years old.
  • Duration of diabetic illness started since at least three years.
  • Patients with mild to moderate neuropathy according to Toronto clinical neuropathy score
  • Patients with cognitive function ranges from 24 - 15 score according to Mini mental state examination
  • Patients with HbA1c ranges from seven to nine score.
  • Ambulant patients with or without walking aids.
  • Medically and psychologically stable patients without cardiac problems, confirmed by Electro Cardiogram (ECG).
  • able to understand instructions.

Exclusion criteria

  • Type I diabetes mellitus.
  • Severe visual, verbal or acoustic impairments.
  • Sever cognitive dysfunctions or that caused by other cause rather than diabetes mellitus.
  • Polyneuropathy caused by other cause rather than diabetes mellitus.
  • Other neurological problem as stroke.
  • Cardiovascular problems.
  • Metallic implants
  • Illiterate patients.
  • Uncooperative patients.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

control group
Experimental group
Description:
The control group (GI) will receive a computer based cognitive rehabilitation program (Rehacom system)
Treatment:
Other: A computer based cognitive rehabilitation program (Rehacom system)
study group
Experimental group
Description:
The study group (GII) will receive a computer based cognitive rehabilitation program (Rehacom system) in addition to Vagus nerve stimulation.
Treatment:
Other: A computer based cognitive rehabilitation program (Rehacom system)
Device: Vagus nerve stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems